Form 4: CONMED Corp Director Charles Farkas Sells 4,000 Shares
SEC Form 4
Director Charles Farkas sold 4,000 shares of CONMED Corp stock at $56.942 per share on May 5, 2025.
Summary
- Charles Farkas, a director of CONMED Corp, sold 4,000 shares of common stock on May 5, 2025.
- The sale price was $56.942 per share.
- Following the transaction, Farkas directly owns 16,346 shares of CONMED Corp.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of a transaction by a company insider. It's common for directors and officers to buy and sell shares of their company's stock.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder confidence, but is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 05/05/2025 | Date of transaction: Sale of 4,000 shares of common stock. |
| 05/06/2025 | Date of signature for the report. |
Keywords
CONMED Corp, Charles Farkas, stock sale, Form 4, director, CNMD, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.